Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility

Cancers(2020)10.3390/cancers12040948Source: DataRank Database

Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility is a research paper published in Cancers (2020). On theSindex it has a DataRank of 0. It has been cited 43 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access43 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)OA: goldTopics (14)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Aparna Gorthi ORCID,Nicklas Bassani ORCID,Liesl A. Lawrence ORCID,Brian S. Iskra ORCID,Alexander J.R. Bishop ORCID

Live enrichment

PubMed:26207759

National Institutes of Health

Grant: 1R01CA152063

National Institutes of Health

Grant: 1R01CA241554

National Institutes of Health

Grant: TL1TR002647

National Institutes of Health

Grant: P30CA054174

National Institutes of Health

Grant: T32GM113896 / STXMSTP

National Institutes of Health

Grant: 1S10OD021805-01

High Throughput DNA Sequencer: Illumina HiSeq 3000 Sequencer

Cancer Prevention and Research Institute of Texas

Grant: RP150445

Cancer Prevention and Research Institute of Texas

Grant: RP101491

Cancer Prevention and Research Institute of Texas

Grant: RP160732

National Cancer Institute

Grant: T32CA148724

AACR-AstraZeneca

Grant: 18-40-12-GORT

Congressionally Directed Medical Research Programs

Grant: W81XWH-19-1-0180

National Institute on Aging

Grant: F30 AG057213

National Institutes of Health

Grant: 5R01CA241554-04

Dysregulated transcription processes in Ewing sarcoma

National Institutes of Health

Grant: 5P30CA054174-16

SAN ANTONIO CANCER INSTITUTE

National Institutes of Health

Grant: 1TL1TR002647-01

NRSA Training Core (TL1)

National Institutes of Health

Grant: 3T32GM113896-03S1

South Texas Medical Scientist Training Program (STX-MSTP)

National Institutes of Health

Grant: 5R01CA152063-04

Improving etoposide treatment of Ewing's sarcoma

National Institutes of Health

Grant: 1F30AG057213-01

Targeting Doxorubicin-Induced Mitochondrial Failure in Mesenchymal Stem Cells with Metformin

National Institutes of Health

Grant: 5T32CA148724-08

Cancer Biology Training Program

goldLicense: cc-by

publisherhttps://www.mdpi.com/2072-6694/12/4/948/pdf?version=1587654843

publisherhttps://www.mdpi.com/2072-6694/12/4/948/pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7226175

repositoryhttps://doaj.org/article/4f8985b546884b24b496935f57ab64cf

repositoryhttp://dx.doi.org/10.3390/cancers12040948

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

sarcomagenesisreplication stressEWSR1-FLI1single cell biologyR-loopsArticletranscriptomicsmanifold learningdevelopmental trajectoriesEwing sarcomacell identity

Sustainable Development Goals

SDG 3: 3. Good health